Avai Bio annual depreciation and amortization
2019
2020
2023
2024
2025
2026
Avai Bio Depreciation & Amortization Growth & History (AVAI)
Avai Bio's depreciation and amortization was $26,070 for fiscal 2026.
View full Avai Bio company overviewAvai Bio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $26,070 | −$48,250 | −64.92% |
| 2025 | 2025-03-31 | $74,320 | −$2,633 | −3.42% |
| 2024 | 2024-03-31 | $76,953 | $53,536 | +228.62% |
| 2023 | 2023-03-31 | $23,417 | — | — |
| 2020 | 2020-03-31 | $39,102 | $34,300 | +714.29% |
| 2019 | 2019-03-31 | $4,802 | — | — |
Avai Bio quarterly depreciation and amortization
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q1.27
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $5,244 | −$1,274 | −19.55% |
| Q4 2026 | 2026-03-31 | $6,518 | −$9,249 | −58.66% |
| Q3 2026 | 2025-12-31 | $6,517 | −$13,000 | −66.61% |
| Q2 2026 | 2025-09-30 | $6,517 | −$13,000 | −66.61% |
| Q1 2026 | 2025-06-30 | $6,518 | −$12,999 | −66.60% |
| Q4 2025 | 2025-03-31 | $15,767 | — | — |
| Q3 2025 | 2024-12-31 | $19,517 | $9,250 | +90.09% |
| Q2 2025 | 2024-09-30 | $19,517 | $9,200 | +89.17% |
| Q1 2025 | 2024-06-30 | $19,517 | $10,416 | +114.45% |
| Q3 2024 | 2023-12-31 | $10,267 | — | — |
| Q2 2024 | 2023-09-30 | $10,317 | — | — |
| Q1 2024 | 2023-06-30 | $9,101 | — | — |
| Q3 2021 | 2020-12-31 | $14,124 | $5,932 | +72.41% |
| Q2 2021 | 2020-09-30 | $14,048 | $4,213 | +42.84% |
| Q1 2021 | 2020-06-30 | $14,459 | $14,384 | +19178.67% |
| Q3 2020 | 2019-12-31 | $8,192 | $6,027 | +278.38% |
| Q2 2020 | 2019-09-30 | $9,835 | $9,363 | +1983.69% |
| Q1 2020 | 2019-06-30 | $75 | $75 | — |
| Q3 2019 | 2018-12-31 | $2,165 | — | — |
| Q2 2019 | 2018-09-30 | $472 | — | — |
| Q1 2019 | 2018-06-30 | $0 | — | — |
Avai Bio depreciation and amortization trends
Between the periods ended 2019-03-31 and 2026-03-31, Avai Bio's depreciation and amortization increased from $4,802 to $26,070, a change of $21,268. The latest reported quarter, Q1 2027, shows $5,244.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Avai Bio source filings ↗